Quadrant Pharmaceuticals has contributed to the advancement of coronavirus diagnostic research and testing initiatives, supporting scientific efforts focused on the detection, monitoring, and understanding of SARS-CoV-2. Our work encompasses diagnostic research, laboratory testing methodologies, and the evaluation of innovative approaches designed to improve the speed, reliability, and accessibility of infectious-disease testing. Building on the scientific capabilities developed during the COVID-19 pandemic, Quadrant continues to advance its research and diagnostic interests in emerging infectious diseases, with a focus on science-driven solutions that support public health preparedness and improved patient outcomes. Modern SARS-CoV-2 diagnostics include molecular methods such as PCR/NAAT and antigen-based testing, which are used to identify current infection. (CDC)
Science and innovation are at the heart of our approach to advancing biopharmaceutical research and developing solutions for evolving healthcare needs.
– Quadrant Pharmaceuticals
Lillian Rice
Quadrant Pharmaceuticals demonstrates a strong commitment to scientific excellence and quality. Their professional and collaborative approach makes them a valuable partner in pharmaceutical research and development.
Irene Doyon
We were impressed by the professionalism, technical expertise, and responsiveness of the Quadrant Pharmaceuticals team. Their quality-focused approach gives us confidence in every stage of collaboration.
James Moore
Quadrant Pharmaceuticals combines scientific expertise with a clear commitment to quality and innovation. Their team is reliable, knowledgeable, and focused on delivering high-quality biopharmaceutical solutions.